Screening Best Practices

The global cost of cancer is projected to reach a staggering $25 trillion (USD) by 2050. Implementing proper screening procedures and detecting cancer early is crucial for enhancing treatment and boosting survival.

Significant strides have been made in implementing screening programmes for breast, cervical, and colorectal cancers across Europe. Updates in 2022 set even more ambitious targets, expanding these efforts to include six cancer types: breast, cervical, colorectal, gastric, lung, and prostate. Nevertheless, it is essential that these programmes uphold the highest levels of professional standards and quality assurance, and that they are implemented in a coordinated, nationwide manner.

With the collaboration of screening experts and healthcare professionals, we have collected and analysed their experiences and input, through both our survey and the ECO country visits.  

We are pleased to present some of the preliminary results, which include key recommendations on the six types of screening. In this respect, we are in the process of gathering further data and liaising with experts, member societies and the cancer community, to develop a comprehensive set of recommendations for 2025 which will include:

  • More in-depth analysis of the benefits of using walk-in mobile screening units (where possible) in locations outside medical institutions and hospitals, with prior appointments not being required e.g. convenient public places such as shopping centres, sporting events etc. This option must be seriously considered, as there is already anecdotal evidence that such screening units reach citizens who would not normally respond to traditional calls for screening.
  • Effective strategies for engaging the recommended population target group, through upbeat awareness and education strategies.
  • More data targeting recent recommended screening including lung, prostate and gastric by involving experts and coordinating with EU-funded projects focused on the implementation of such screening in Europe.

The Cancer Screening Best Practices Survey focused on bringing testimonies from leading national experts who develop and implement cancer screening policies to better understand and document what best practices can be learned. In particular, we have reached out to healthcare professionals to collect their testimonies.

You will see below the feedback we have received, summarised by tumour type. Some feedback (such as the method of communication on screening appointments) is repeated where experts mentioned this as a priority for that type of cancer, based on their experience.

View More

  • Screening Experiences

    Read More